文献速递神经肿瘤

立体定向放射外科在岩斜区脑膜瘤管理中的作用:一项系统综述

The role of stereotactic radiosurgery in the management of petroclival meningioma: a systematic review.
PubMed 文献 · J Neurooncol · 2022-06-18

该系统综述基于PRISMA指南检索截至2022年2月16日的文献,纳入10项研究共719例岩斜区脑膜瘤患者,评估立体定向放射外科(SRS)的治疗作用。SRS后中位随访64.52个月,肿瘤控制率中位98.8%,并发症发生率6%,以脑积水(2.2%)最常见。SRS作为主要治疗与并发症率增加无关(RR 0.62,95%CI 0.11-3.59,p=0.59),但与临床失败统计学相关(RR 0.56,95%CI 0.32-0.98,p=0.04)。

要点

  • SRS后肿瘤缩小者占46.5%,无变化占46%,增大占7.5%。
  • SRS后并发症发生率6%,脑积水(2.2%)为最常见并发症。
  • SRS作为主要治疗与临床失败相关(RR 0.56,95%CI 0.32-0.98,p=0.04)。

核心结论

  • SRS干预后并发症发生率低,并有效控制肿瘤进展。

研究设计与样本

  • 系统综述,遵循PRISMA指南,检索EuroPMC和PubMed截至2022年2月16日的同行评议英文文献。
  • 从266项研究中纳入10项研究(其中2项为病例报告),共719例患者。

主要发现

  • 719例患者中女性占73.7%(n=530),中位年龄56.99岁(范围18-90岁)。
  • 诊断时中位肿瘤体积6.07 cm3(范围0.13-64.9 cm3),83.6%(n=598)的肿瘤位于岩斜交界区附近。
  • SRS后中位随访64.52个月(范围3-252个月),46.5%的肿瘤缩小,46%无变化,7.5%增大。
  • 末次影像学随访(7-21.2年)肿瘤控制率中位98.8%(范围85-100%)。
  • 并发症发生率6%,以脑积水(2.2%)最常见。

关键数值与推荐

  • SRS作为岩斜区病例的主要治疗与并发症率增加无关:RR 0.62(95%CI 0.11-3.59,p=0.59)。
  • SRS作为主要治疗与临床失败统计学相关:RR 0.56(95%CI 0.32-0.98,p=0.04)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Petroclival meningioma (PM) is a challenging neuro oncology case and stereotactic radiosurgery (SRS) is proposed as one treatment option. This systematic review aimed to examine the role of SRS in treating PM cases. METHODS: We constructed a systematic review using the PRISMA guidelines using peer-reviewed English literature until 16 February 2022 from EuroPMC and PubMed. We used the terms petroclival meningioma, clival meningioma, apex petrous meningioma, spheno petroclival meningioma, stereotactic radiosurgery, radiosurgery, CyberKnife, Gamma Knife, linear accelerator, LINAC, and radiotherapy. RESULTS: 10 out of 266 studies were chosen for this systematic review, two of which are case reports. The study comprised 719 patients, 73.7% of whom were female (n = 530) and had a median age of 56.99 years (18-90 years). At the time of diagnosis, the median tumor volume was 6.07 cm3 (0.13-64.9 cm3). The tumors were frequently located near the petroclival junction (83.6%, n = 598). Following SRS, the median follow-up was 64.52 months (3-252 months). 46.5% of 719 PMs exhibited a decrease in tumor size. 46% and 7.5% showed no change and increase in tumor volume, respectively. At the last radiographic follow-up (7-21.2 years), tumor control with a median of 98.8% (85-100%). Complications occurred in 6% of patients, with hydrocephalus (2.2%) as the prevalent complication. The use of SRS as a primary treatment for petroclival cases was not associated with increased complication rate RR 0.62 (95% CI [0.11, 3.59], p = 0.59) but statistically correlated with clinical failure clinical failure RR 0.56 (95% CI [0.32, 0.98], p = 0.04). CONCLUSIONS: We found a low number of complications following SRS intervention and has been effectively controlling tumor progression.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Wijaya JH, Arjuna YYE, July J, et al. The role of stereotactic radiosurgery in the management of petroclival meningioma: a systematic review. J Neurooncol. 2022. PMID: 35717468. doi:10.1007/s11060-022-04041-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。